John R. Moore's most recent trade in Edgewise Therapeutics Inc was a trade of 5,209 Restricted Stock Units done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 5,209 | 0 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 5,209 | 8,461 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 01 May 2025 | 1,930 | 6,531 | - | 16.5 | 31,757 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2024 | 50,000 | 62,558 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 20 Sep 2024 | 50,000 | 3,252 | - | 28.4 | 1,418,510 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 20 Sep 2024 | 50,000 | 53,252 | - | 0.7 | 35,500 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2024 | 20,922 | 41,636 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 27.63 per share. | 20 Sep 2024 | 20,922 | 3,252 | - | 27.6 | 578,064 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 20 Sep 2024 | 20,922 | 24,174 | - | 0.7 | 14,855 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 138,750 | 138,750 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 23,125 | 23,125 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 5,208 | 5,208 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 5,208 | 5,209 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 18.91 per share. | 01 May 2024 | 1,956 | 3,252 | - | 18.9 | 36,988 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 07 Feb 2024 | 17,993 | 0 | - | 20.0 | 359,864 | Common Stock |
| Edgewise Therapeutics Inc | R. Moore John | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 17,993 | 105,004 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | R. Moore John | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 07 Feb 2024 | 17,993 | 17,993 | - | 1.9 | 34,726 | Common Stock |
| Edgewise Therapeutics Inc | Moore John R. | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 8,029 | 93,162 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 07 Feb 2024 | 8,029 | 8,029 | - | 1.9 | 15,496 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 07 Feb 2024 | 8,029 | 0 | - | 20.0 | 160,657 | Common Stock |
| Edgewise Therapeutics Inc | R. John Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 3,813 | 101,191 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Moore John R. | General Counsel | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 07 Feb 2024 | 3,813 | 0 | - | 20.0 | 76,285 | Common Stock |
| Edgewise Therapeutics Inc | R. Moore John | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 07 Feb 2024 | 3,813 | 3,813 | - | 1.9 | 7,359 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 10.50 per share. | 27 Dec 2023 | 8,497 | 0 | - | 10.5 | 89,219 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 5,208 | 10,417 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 5,208 | 8,462 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 01 May 2023 | 1,897 | 6,565 | - | 8.9 | 16,893 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 4,730 | 122,997 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 03 Oct 2022 | 4,730 | 7,730 | - | 1.9 | 9,129 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 9.76 per share. | 03 Oct 2022 | 4,730 | 3,000 | - | 9.8 | 46,155 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 06 Sep 2022 | 4,730 | 7,730 | - | 1.9 | 9,129 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2022 | 4,730 | 127,727 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 10.83 per share. | 06 Sep 2022 | 2,379 | 5,351 | - | 10.8 | 25,756 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 10.99 per share. | 06 Sep 2022 | 2,351 | 3,000 | - | 11.0 | 25,842 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 9.31 per share. | 03 Aug 2022 | 9,232 | 3,000 | - | 9.3 | 85,921 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 4,730 | 132,457 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 03 Aug 2022 | 4,730 | 7,730 | - | 1.9 | 9,129 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 03 Aug 2022 | 4,502 | 12,232 | - | 0.7 | 3,196 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 4,502 | 112,558 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 8.35 per share. | 05 Jul 2022 | 8,186 | 3,000 | - | 8.3 | 68,329 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 05 Jul 2022 | 4,502 | 11,186 | - | 0.7 | 3,196 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 4,502 | 117,060 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 3,684 | 138,233 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 05 Jul 2022 | 3,684 | 6,684 | - | 1.9 | 7,110 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 1,046 | 137,187 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 8.54 per share. | 05 Jul 2022 | 1,046 | 3,000 | - | 8.5 | 8,928 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 05 Jul 2022 | 1,046 | 4,046 | - | 1.9 | 2,019 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 7.29 per share. | 16 Jun 2022 | 31,078 | 3,000 | - | 7.3 | 226,695 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 16 Jun 2022 | 22,127 | 25,127 | - | 1.9 | 42,705 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 16 Jun 2022 | 22,127 | 3,000 | - | 6.6 | 146,434 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 22,127 | 159,487 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 16 Jun 2022 | 17,570 | 34,078 | - | 1.9 | 33,910 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 17,570 | 141,917 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 16 Jun 2022 | 14,722 | 17,722 | - | 1.9 | 28,413 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 14,722 | 181,614 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 16 Jun 2022 | 14,722 | 3,000 | - | 6.2 | 90,805 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 16 Jun 2022 | 13,508 | 16,508 | - | 0.7 | 9,591 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 13,508 | 121,562 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 13 Jun 2022 | 18,075 | 21,075 | - | 0.7 | 12,833 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 13 Jun 2022 | 18,075 | 3,000 | - | 6.1 | 110,445 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2022 | 18,075 | 135,070 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 13 Jun 2022 | 4,093 | 7,093 | - | 0.7 | 2,906 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.01 per share. | 13 Jun 2022 | 4,093 | 3,000 | - | 6.0 | 24,582 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2022 | 4,093 | 156,773 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2022 | 3,628 | 153,145 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 13 Jun 2022 | 3,628 | 6,628 | - | 0.7 | 2,576 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.02 per share. | 13 Jun 2022 | 3,628 | 3,000 | - | 6.0 | 21,855 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 13 Jun 2022 | 585 | 21,660 | - | 1.9 | 1,129 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 13 Jun 2022 | 585 | 21,075 | - | 6.1 | 3,575 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2022 | 585 | 196,336 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 12,566 | 175,606 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 08 Jun 2022 | 12,566 | 3,000 | - | 6.6 | 83,362 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 08 Jun 2022 | 12,566 | 15,566 | - | 0.7 | 8,922 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.49 per share. | 08 Jun 2022 | 7,615 | 3,000 | - | 6.5 | 49,397 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 08 Jun 2022 | 7,615 | 10,615 | - | 0.7 | 5,407 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 7,615 | 167,991 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.05 per share. | 08 Jun 2022 | 7,125 | 3,000 | - | 6.1 | 43,120 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 08 Jun 2022 | 7,125 | 10,125 | - | 0.7 | 5,059 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 7,125 | 160,866 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2022 | 17,150 | 188,172 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.61 per share. | 03 Jun 2022 | 17,150 | 3,000 | - | 6.6 | 113,276 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 03 Jun 2022 | 17,150 | 20,150 | - | 0.7 | 12,177 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 03 Jun 2022 | 15,230 | 18,230 | - | 1.9 | 29,394 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.05 per share. | 03 Jun 2022 | 15,230 | 3,000 | - | 6.1 | 92,198 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2022 | 15,230 | 211,828 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.03 per share. | 03 Jun 2022 | 13,934 | 3,000 | - | 6.0 | 84,085 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 03 Jun 2022 | 13,934 | 16,934 | - | 1.9 | 26,893 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2022 | 13,934 | 197,894 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2022 | 973 | 196,921 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.61 per share. | 03 Jun 2022 | 973 | 3,000 | - | 6.6 | 6,427 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share. | 03 Jun 2022 | 973 | 3,973 | - | 1.9 | 1,878 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 7.42 per share. | 16 May 2022 | 10,800 | 3,000 | - | 7.4 | 80,146 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2022 | 15,625 | 15,625 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 5,400 | 205,322 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 21 Jan 2022 | 5,400 | 12,362 | - | 0.7 | 3,834 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 5,400 | 210,722 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 28 Dec 2021 | 5,400 | 6,962 | - | 0.7 | 3,834 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) |